← Back
Data updated: Mar 29, 2026
Cipla
Infectious DiseaseOncologyImmunology
Generics
Cipla is a generic drug manufacturer focused on Infectious Disease, Oncology, Immunology. Key products include ZEMDRI.
2001
Since
122
Drugs
-
Trials
858
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 29%
8 drugs
Oncology 25%
7 drugs
Immunology 18%
5 drugs
Respiratory 17%
2 drugs Phase 3: 4
Cardiovascular 11%
3 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Novartis big-pharma
Oncology, Cardiovascular, Immunology, Respiratory
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular
GSK big-pharma
Infectious Disease, Respiratory, Oncology, Immunology
Sanofi big-pharma
Oncology, Infectious Disease, Immunology, Respiratory
Active (59)
NILOTINIB D-TARTRATE GEFITINIB DIFLUPREDNATE ARFORMOTEROL TARTRATE LENALIDOMIDE TAVABOROLE FOSFOMYCIN TROMETHAMINE VASOPRESSIN POTASSIUM PHOSPHATES ICATIBANT ACETATE SELENIOUS ACID AMBRISENTAN EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE ZEMDRI TADALAFIL DARUNAVIR CASPOFUNGIN ACETATE LOPINAVIR AND RITONAVIR SUMATRIPTAN DEFERASIROX TENOFOVIR DISOPROXIL FUMARATE DARIFENACIN HYDROBROMIDE ESOMEPRAZOLE MAGNESIUM RITONAVIR BEXAROTENE CELECOXIB SOLIFENACIN SUCCINATE AZACITIDINE RANOLAZINE DECITABINE ABACAVIR SULFATE LAMIVUDINE ANASTROZOLE BUDESONIDE CALCITONIN-SALMON NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE LEVALBUTEROL HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE ALENDRONATE SODIUM FAMCICLOVIR PANTOPRAZOLE SODIUM VALACYCLOVIR HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE PRAVASTATIN SODIUM RAMIPRIL ANAGRELIDE HYDROCHLORIDE GRISEOFULVIN MELOXICAM TOPIRAMATE DIHYDROERGOTAMINE MESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM ACYCLOVIR DICLOFENAC SODIUM ALBUTEROL SULFATE CYCLOPHOSPHAMIDE TESTOSTERONE CYPIONATE PHYTONADIONE GLUCAGON
Discontinued (36)
PREGABALIN AMLODIPINE BESYLATE ZOLEDRONIC ACID HYDROCORTISONE SODIUM SUCCINATE CARBOPLATIN CETIRIZINE HYDROCHLORIDE ALLERGY FINASTERIDE FENOFIBRATE TESTOSTERONE ISOPROTERENOL HYDROCHLORIDE EXEMESTANE MONTELUKAST SODIUM ZIDOVUDINE TERBINAFINE HYDROCHLORIDE PACLITAXEL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE METOPROLOL SUCCINATE NEVIRAPINE CINACALCET HYDROCHLORIDE SIPONIMOD VALGANCICLOVIR HYDROCHLORIDE ABACAVIR SULFATE AND LAMIVUDINE DONEPEZIL HYDROCHLORIDE MEDROXYPROGESTERONE ACETATE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE DIMETHYL FUMARATE ENTECAVIR ELIGLUSTAT TARTRATE LAMIVUDINE AND ZIDOVUDINE EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE ALBENDAZOLE SODIUM NITROPRUSSIDE ARGATROBAN IN SODIUM CHLORIDE STAVUDINE BLEOMYCIN SULFATE FLUTAMIDE
Company Info
- First Approval
- 2001-09-19
- Latest
- 2026-02-02
- Applications
- 163
FDA Sponsor Names
CIPLACIPLA USACIPLA LTDCIPLA LIMITEDCIPLA USA INC.